Trial Profile
A phase III, randomized, parallel group study to compare the therapeutic efficacy of SMB BUDESONIDE-SALMETEROL DPI capsule 300/25microg BID delivered by the AXAHALER versus SERETIDE DISKUS 500/50microg (Fluticasone propionate 500microg/Salmeterol 50microg) BID over 12 weeks and to evaluate the safety of SMB BUDESONIDE-SALMETEROL 300/25microg over an additional period of 12 weeks in moderate to severe persistent asthmatic patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jun 2011
Price :
$35
*
At a glance
- Drugs Budesonide/salmeterol (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms BUSAL
- 29 Jun 2011 New trial record